20 authors.
Olivia PriorFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0009-0000-4913-6716 Carlos MacarroFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0009-0000-0597-9316 Víctor NavarroFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0000-0001-6925-4605 Camilo MonrealFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0009-0001-1025-0770 Marta LigeroFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0000-0001-9824-7316 Alonso Garcia-RuizFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0000-0003-0129-3020 Garazi SernaFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).
Sara SimonettiFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).
Irene BrañaFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).
Maria VieitoFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).
Manuel EscobarFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0000-0002-3794-2224 Jaume CapdevilaFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).
Annette T ByrneFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).
Rodrigo DienstmannFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0000-0001-5997-318X Rodrigo ToledoFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0000-0003-3070-6795 Paolo NuciforoFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0000-0003-1380-0990 Elena GarraldaFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0000-0002-4412-7842 Francesco GrussuFrom the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0000-0002-0945-3909 Kinga Bernatowicz *From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0000-0001-9166-1709 Raquel Perez-Lopez *From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).ORCID 0000-0002-9176-0130 No grant is acknowledged in the PubMed record.